Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (3)
  • 2023 (7)
  • 2022 (15)
  • 2021 (6)

Subject

  • Drug Trafficking (72)
  • Guilty Plea (36)
  • Guns/Weapons (34)
  • Arrests/Convictions - Major (27)
  • HIDTA (27)
  • Gangs (22)
  • Synthetic drugs (22)
  • OCDETF/Task Force (17)
  • Seizures (Drugs/Property) (16)
  • Prescription Drugs (15)
  • Pharmaceuticals/Pharmacists/Physicians (11)
  • Money Laundering (10)
  • Major Law Enforcement Operation (9)
  • Take Back Day (9)
  • Fake Pills (8)
  • Press Conferences (6)
  • International/Foreign Operations (4)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Fentanyl Awareness (3)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Dark Web- Internet Trafficking (2)
  • Extraditions (2)
  • Outreach/Drug Prevention (2)
  • Overdose (2)
  • Intergovernmental Affairs (1)
  • One Pill Can Kill (1)
  • Terrorism (1)
  • Task Forces/Task Force Officers (18)
  • Diversion Division (14)

Drug Name

  • Cocaine (7)
  • Fentanyl (4)
  • Heroin (4)
  • Oxycodone (3)
  • Methamphetamine (1)

Field Division

  • Washington, DC (182)
  • New England (42)
  • New York (35)
  • Seattle (23)
  • Chicago (21)
  • Houston (16)
  • Atlanta (13)
  • Miami (12)
  • San Francisco (10)
  • Sede (10)
  • El Paso (9)
  • New Orleans (9)
  • Dallas (7)
  • St. Louis (7)
  • San Diego (6)
  • Omaha (5)
  • Rocky Mountain (5)
  • Los Angeles (3)
  • Louisville (3)
  • Phoenix (3)
  • Detroit (1)
  • New Jersey (31)
Clear All Results
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

Abril 10, 2024
NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
Abril 10, 2024
PRESS RELEASE

Owner Of New Jersey Company Admits to Evading U.S. Customs Duties and His Company Agrees to a $3.1 Million Settlement Agreement

Marzo 29, 2024
NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...
Marzo 29, 2024
PRESS RELEASE

Gang Member Sentenced to 12 Years in Prison for Racketeering

Febrero 08, 2024
NEWARK, N.J. – A member of the Rollin’ 60s Neighborhood Crips gang was sentenced today to 144 months in prison for his role in a racketeering conspiracy, Special Agent in Charge Cheryl Ortiz of the DEA New Jersey Field Division and U.S. Attorney Philip R. Sellinger announced today. Tre Byrd...
Febrero 08, 2024
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

Octubre 04, 2023
NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
Octubre 04, 2023
PRESS RELEASE

Five Men Charged With Using New York Diamond District Companies As Front To Illegally Move More Than $600 Million

Septiembre 11, 2023
NEWARK, NJ. – Five men who work in New York City’s Diamond District were arrested today and charged with illegally processing more than $600 million through unlicensed money transmitting businesses, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and U.S. Attorney Philip R...
Septiembre 11, 2023
PRESS RELEASE

Essex County Man Sentenced to 10 Years in Prison for Illegally Possessing Firearms and Drug Trafficking

Agosto 17, 2023
NEWARK, N.J. – An Essex County, New Jersey man was sentenced today to 10 years in prison for illegal drug distribution and weapons offenses, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Keith Rogers, 46, of...
Agosto 17, 2023
PRESS RELEASE

Toms River Woman Charged with Unauthorized Practice of Medicine, Forgery, Health Care Claims Fraud, and Distribution of a Controlled Dangerous Substance

Julio 27, 2023
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and Ocean County Prosecutor Bradley D. Billhimer announced that on July 25, 2023, Maria F. Macburnie, aka Marife L. Macburnie, 62, of Toms River, was charged with Practicing Medicine by an Unlicensed...
Julio 27, 2023
PRESS RELEASE

Gloucester County Man Admits Healthcare Fraud

Junio 13, 2023
CAMDEN, N.J. – A Gloucester County, New Jersey, man today admitted defrauding his employer’s health insurance plan out of more than $4 million by submitting fraudulent claims for medically unnecessary compounded medications, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Cheryl Ortiz and Attorney for the...
Junio 13, 2023
PRESS RELEASE

Passaic County Man Sentenced to 150 Months in Prison for Distributing Fentanyl that Led to Overdose Death

Abril 05, 2023
NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a Passaic County, New Jersey, man was sentenced today to 150 months in prison for distributing fentanyl that...
Abril 05, 2023
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

Febrero 15, 2023
NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...
Febrero 15, 2023
Showing 1 - 10 of 31 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster